China Antibacterial (Drug) Resistance Market Report & Forecast 2021-2027

China Antibacterial (Drug) Resistance Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Antibacterial (Drug) Resistance Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Indication
1.3 China Antibacterial (Drug) Resistance Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Antibacterial (Drug) Resistance Overall Market Size
2.1 China Antibacterial (Drug) Resistance Market Size: 2021 VS 2027
2.2 China Antibacterial (Drug) Resistance Revenue, Prospects & Forecasts: 2016-2027
2.3 China Antibacterial (Drug) Resistance Sales: 2016-2027
3 Company Landscape
3.1 Top Antibacterial (Drug) Resistance Players in China Market
3.2 Top China Antibacterial (Drug) Resistance Companies Ranked by Revenue
3.3 China Antibacterial (Drug) Resistance Revenue by Companies
3.4 China Antibacterial (Drug) Resistance Sales by Companies
3.5 China Antibacterial (Drug) Resistance Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Antibacterial (Drug) Resistance Companies in China Market, by Revenue in 2020
3.7 Manufacturers Antibacterial (Drug) Resistance Product Type
3.8 Tier 1, Tier 2 and Tier 3 Antibacterial (Drug) Resistance Players in China Market
3.8.1 List of Tier 1 Antibacterial (Drug) Resistance Companies in China
3.8.2 List of Tier 2 and Tier 3 Antibacterial (Drug) Resistance Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Antibacterial (Drug) Resistance Market Size Markets, 2021 & 2027
4.1.2 Telavancin (Vibativ)
4.1.3 Ceftaroline Fosamil (Teflaro/ Zinforo)
4.1.4 Fidaxomicin (Dificid / Dificlir)
4.1.5 Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio)
4.1.6 Dalbavancin (Dalvance/ Xydalba)
4.1.7 Tedizolid Phosphate (Sivextro)
4.1.8 Oritavancin (Orbactiv/ Nuvocid)
4.1.9 Ceftolozane-Tazobactam (Zerbaxa)
4.1.10 Ceftazidime-Avibactam (Avycaz/ Zavicefta)
4.1.11 PHASE III DRUGS
4.2 By Type - China Antibacterial (Drug) Resistance Revenue & Forecasts
4.2.1 By Type - China Antibacterial (Drug) Resistance Revenue, 2016-2021
4.2.2 By Type - China Antibacterial (Drug) Resistance Revenue, 2022-2027
4.2.3 By Type - China Antibacterial (Drug) Resistance Revenue Market Share, 2016-2027
4.3 By Type - China Antibacterial (Drug) Resistance Sales & Forecasts
4.3.1 By Type - China Antibacterial (Drug) Resistance Sales, 2016-2021
4.3.2 By Type - China Antibacterial (Drug) Resistance Sales, 2022-2027
4.3.3 By Type - China Antibacterial (Drug) Resistance Sales Market Share, 2016-2027
4.4 By Type - China Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Indication
5.1 Overview
5.1.1 By Indication - China Antibacterial (Drug) Resistance Market Size, 2021 & 2027
5.1.2 Complicated Urinary Tract Infection (CUTI)
5.1.3 Complicated Intra-Abdominal Infections (CIAI)
5.1.4 Blood Stream Infections (BSI)
5.1.5 Clostridium Difficile Infections (CDI)
5.1.6 Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
5.1.7 Hospital Acquired Bacterial Pneumonia/Ventilator (HABP/VABP)
5.1.8 Community Acquired Bacterial Pneumonia (CABP)
5.2 By Indication - China Antibacterial (Drug) Resistance Revenue & Forecasts
5.2.1 By Indication - China Antibacterial (Drug) Resistance Revenue, 2016-2021
5.2.2 By Indication - China Antibacterial (Drug) Resistance Revenue, 2022-2027
5.2.3 By Indication - China Antibacterial (Drug) Resistance Revenue Market Share, 2016-2027
5.3 By Indication - China Antibacterial (Drug) Resistance Sales & Forecasts
5.3.1 By Indication - China Antibacterial (Drug) Resistance Sales, 2016-2021
5.3.2 By Indication - China Antibacterial (Drug) Resistance Sales, 2022-2027
5.3.3 By Indication - China Antibacterial (Drug) Resistance Sales Market Share, 2016-2027
5.4 By Indication - China Antibacterial (Drug) Resistance Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 Melinta Therapeutics
6.1.1 Melinta Therapeutics Corporation Information
6.1.2 Melinta Therapeutics Overview
6.1.3 Melinta Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.1.4 Melinta Therapeutics Antibacterial (Drug) Resistance Product Description
6.1.5 Melinta Therapeutics Recent Developments
6.2 Allergan
6.2.1 Allergan Corporation Information
6.2.2 Allergan Overview
6.2.3 Allergan Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.2.4 Allergan Antibacterial (Drug) Resistance Product Description
6.2.5 Allergan Recent Developments
6.3 Merck
6.3.1 Merck Corporation Information
6.3.2 Merck Overview
6.3.3 Merck Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.3.4 Merck Antibacterial (Drug) Resistance Product Description
6.3.5 Merck Recent Developments
6.4 Abbott Laboratories
6.4.1 Abbott Laboratories Corporation Information
6.4.2 Abbott Laboratories Overview
6.4.3 Abbott Laboratories Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.4.4 Abbott Laboratories Antibacterial (Drug) Resistance Product Description
6.4.5 Abbott Laboratories Recent Developments
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Overview
6.5.3 Pfizer Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.5.4 Pfizer Antibacterial (Drug) Resistance Product Description
6.5.5 Pfizer Recent Developments
6.6 GSK
6.6.1 GSK Corporation Information
6.6.2 GSK Overview
6.6.3 GSK Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.6.4 GSK Antibacterial (Drug) Resistance Product Description
6.6.5 GSK Recent Developments
6.7 PENDOPHARM
6.7.1 PENDOPHARM Corporation Information
6.7.2 PENDOPHARM Overview
6.7.3 PENDOPHARM Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.7.4 PENDOPHARM Antibacterial (Drug) Resistance Product Description
6.7.5 PENDOPHARM Recent Developments
6.8 Absynth Biologics
6.8.1 Absynth Biologics Corporation Information
6.8.2 Absynth Biologics Overview
6.8.3 Absynth Biologics Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.8.4 Absynth Biologics Antibacterial (Drug) Resistance Product Description
6.8.5 Absynth Biologics Recent Developments
6.9 Achaogen
6.9.1 Achaogen Corporation Information
6.9.2 Achaogen Overview
6.9.3 Achaogen Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.9.4 Achaogen Antibacterial (Drug) Resistance Product Description
6.9.5 Achaogen Recent Developments
6.10 Acino Holdings
6.10.1 Acino Holdings Corporation Information
6.10.2 Acino Holdings Overview
6.10.3 Acino Holdings Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.10.4 Acino Holdings Antibacterial (Drug) Resistance Product Description
6.10.5 Acino Holdings Recent Developments
6.11 Aventis Pharma
6.11.1 Aventis Pharma Corporation Information
6.11.2 Aventis Pharma Overview
6.11.3 Aventis Pharma Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.11.4 Aventis Pharma Antibacterial (Drug) Resistance Product Description
6.11.5 Aventis Pharma Recent Developments
6.12 Austell Laboratories
6.12.1 Austell Laboratories Corporation Information
6.12.2 Austell Laboratories Overview
6.12.3 Austell Laboratories Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.12.4 Austell Laboratories Antibacterial (Drug) Resistance Product Description
6.12.5 Austell Laboratories Recent Developments
6.13 Assembly Biosciences
6.13.1 Assembly Biosciences Corporation Information
6.13.2 Assembly Biosciences Overview
6.13.3 Assembly Biosciences Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.13.4 Assembly Biosciences Antibacterial (Drug) Resistance Product Description
6.13.5 Assembly Biosciences Recent Developments
6.14 Arpida
6.14.1 Arpida Corporation Information
6.14.2 Arpida Overview
6.14.3 Arpida Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.14.4 Arpida Antibacterial (Drug) Resistance Product Description
6.14.5 Arpida Recent Developments
6.15 Demuris
6.15.1 Demuris Corporation Information
6.15.2 Demuris Overview
6.15.3 Demuris Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.15.4 Demuris Antibacterial (Drug) Resistance Product Description
6.15.5 Demuris Recent Developments
6.16 Evolva Holding
6.16.1 Evolva Holding Corporation Information
6.16.2 Evolva Holding Overview
6.16.3 Evolva Holding Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.16.4 Evolva Holding Antibacterial (Drug) Resistance Product Description
6.16.5 Evolva Holding Recent Developments
6.17 ContraFect
6.17.1 ContraFect Corporation Information
6.17.2 ContraFect Overview
6.17.3 ContraFect Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.17.4 ContraFect Antibacterial (Drug) Resistance Product Description
6.17.5 ContraFect Recent Developments
6.18 Cerexa
6.18.1 Cerexa Corporation Information
6.18.2 Cerexa Overview
6.18.3 Cerexa Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.18.4 Cerexa Antibacterial (Drug) Resistance Product Description
6.18.5 Cerexa Recent Developments
6.19 InterMune
6.19.1 InterMune Corporation Information
6.19.2 InterMune Overview
6.19.3 InterMune Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.19.4 InterMune Antibacterial (Drug) Resistance Product Description
6.19.5 InterMune Recent Developments
6.20 Isis Pharmaceuticals
6.20.1 Isis Pharmaceuticals Corporation Information
6.20.2 Isis Pharmaceuticals Overview
6.20.3 Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.20.4 Isis Pharmaceuticals Antibacterial (Drug) Resistance Product Description
6.20.5 Isis Pharmaceuticals Recent Developments
6.21 Lyndra
6.21.1 Lyndra Corporation Information
6.21.2 Lyndra Overview
6.21.3 Lyndra Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.21.4 Lyndra Antibacterial (Drug) Resistance Product Description
6.21.5 Lyndra Recent Developments
6.22 Microbecide
6.22.1 Microbecide Corporation Information
6.22.2 Microbecide Overview
6.22.3 Microbecide Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.22.4 Microbecide Antibacterial (Drug) Resistance Product Description
6.22.5 Microbecide Recent Developments
6.23 Morphochem
6.23.1 Morphochem Corporation Information
6.23.2 Morphochem Overview
6.23.3 Morphochem Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.23.4 Morphochem Antibacterial (Drug) Resistance Product Description
6.23.5 Morphochem Recent Developments
6.24 Nabriva Therapeutics
6.24.1 Nabriva Therapeutics Corporation Information
6.24.2 Nabriva Therapeutics Overview
6.24.3 Nabriva Therapeutics Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.24.4 Nabriva Therapeutics Antibacterial (Drug) Resistance Product Description
6.24.5 Nabriva Therapeutics Recent Developments
6.25 NanoSafe Coatings
6.25.1 NanoSafe Coatings Corporation Information
6.25.2 NanoSafe Coatings Overview
6.25.3 NanoSafe Coatings Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.25.4 NanoSafe Coatings Antibacterial (Drug) Resistance Product Description
6.25.5 NanoSafe Coatings Recent Developments
6.26 Novexel
6.26.1 Novexel Corporation Information
6.26.2 Novexel Overview
6.26.3 Novexel Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.26.4 Novexel Antibacterial (Drug) Resistance Product Description
6.26.5 Novexel Recent Developments
6.27 Osel
6.27.1 Osel Corporation Information
6.27.2 Osel Overview
6.27.3 Osel Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.27.4 Osel Antibacterial (Drug) Resistance Product Description
6.27.5 Osel Recent Developments
6.28 VenatoRx Pharmaceuticals
6.28.1 VenatoRx Pharmaceuticals Corporation Information
6.28.2 VenatoRx Pharmaceuticals Overview
6.28.3 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.28.4 VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Product Description
6.28.5 VenatoRx Pharmaceuticals Recent Developments
6.29 AAIPharma Services
6.29.1 AAIPharma Services Corporation Information
6.29.2 AAIPharma Services Overview
6.29.3 AAIPharma Services Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.29.4 AAIPharma Services Antibacterial (Drug) Resistance Product Description
6.29.5 AAIPharma Services Recent Developments
6.30 ANTABIO
6.30.1 ANTABIO Corporation Information
6.30.2 ANTABIO Overview
6.30.3 ANTABIO Antibacterial (Drug) Resistance Sales and Revenue in China Market (2016-2021)
6.30.4 ANTABIO Antibacterial (Drug) Resistance Product Description
6.30.5 ANTABIO Recent Developments
7 China Antibacterial (Drug) Resistance Production Capacity, Analysis
7.1 China Antibacterial (Drug) Resistance Production Capacity, 2016-2027
7.2 Antibacterial (Drug) Resistance Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Antibacterial (Drug) Resistance Supply Chain Analysis
9.1 Antibacterial (Drug) Resistance Industry Value Chain
9.2 Antibacterial (Drug) Resistance Upstream Market
9.3 Antibacterial (Drug) Resistance Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Antibacterial (Drug) Resistance Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Antibacterial (Drug) Resistance in China Market
Table 2. Top Antibacterial (Drug) Resistance Players in China Market, Ranking by Revenue (2019)
Table 3. China Antibacterial (Drug) Resistance Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Antibacterial (Drug) Resistance Revenue Share by Companies, 2016-2021
Table 5. China Antibacterial (Drug) Resistance Sales by Companies, (K Units), 2016-2021
Table 6. China Antibacterial (Drug) Resistance Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Antibacterial (Drug) Resistance Price (2016-2021) & (USD/Unit)
Table 8. Manufacturers Antibacterial (Drug) Resistance Product Type
Table 9. List of Tier 1 Antibacterial (Drug) Resistance Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Antibacterial (Drug) Resistance Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of Telavancin (Vibativ)
Table 12. Major Manufacturers of Ceftaroline Fosamil (Teflaro/ Zinforo)
Table 13. By Type - China Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Antibacterial (Drug) Resistance Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Antibacterial (Drug) Resistance Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Antibacterial (Drug) Resistance Sales (K Units), 2016-2021
Table 17. By Type - China Antibacterial (Drug) Resistance Sales (K Units), 2022-2027
Table 18. By Indication - China Antibacterial (Drug) Resistance Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Indication - China Antibacterial (Drug) Resistance Revenue (US$, Mn), 2016-2021
Table 20. By Indication - China Antibacterial (Drug) Resistance Revenue (US$, Mn), 2022-2027
Table 21. By Indication - China Antibacterial (Drug) Resistance Sales (K Units), 2016-2021
Table 22. By Indication - China Antibacterial (Drug) Resistance Sales (K Units), 2022-2027
Table 23. Melinta Therapeutics Corporation Information
Table 24. Melinta Therapeutics Description and Major Businesses
Table 25. Melinta Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 26. Melinta Therapeutics Antibacterial (Drug) Resistance Product
Table 27. Melinta Therapeutics Recent Developments
Table 28. Allergan Corporation Information
Table 29. Allergan Description and Major Businesses
Table 30. Allergan Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 31. Allergan Antibacterial (Drug) Resistance Product
Table 32. Allergan Recent Developments
Table 33. Merck Corporation Information
Table 34. Merck Description and Major Businesses
Table 35. Merck Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 36. Merck Antibacterial (Drug) Resistance Product
Table 37. Merck Recent Developments
Table 38. Abbott Laboratories Corporation Information
Table 39. Abbott Laboratories Description and Major Businesses
Table 40. Abbott Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 41. Abbott Laboratories Antibacterial (Drug) Resistance Product
Table 42. Abbott Laboratories Recent Developments
Table 43. Pfizer Corporation Information
Table 44. Pfizer Description and Major Businesses
Table 45. Pfizer Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 46. Pfizer Antibacterial (Drug) Resistance Product
Table 47. Pfizer Recent Developments
Table 48. GSK Corporation Information
Table 49. GSK Description and Major Businesses
Table 50. GSK Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 51. GSK Antibacterial (Drug) Resistance Product
Table 52. GSK Recent Developments
Table 53. PENDOPHARM Corporation Information
Table 54. PENDOPHARM Description and Major Businesses
Table 55. PENDOPHARM Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 56. PENDOPHARM Antibacterial (Drug) Resistance Product
Table 57. PENDOPHARM Recent Developments
Table 58. Absynth Biologics Corporation Information
Table 59. Absynth Biologics Description and Major Businesses
Table 60. Absynth Biologics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 61. Absynth Biologics Antibacterial (Drug) Resistance Product
Table 62. Absynth Biologics Recent Developments
Table 63. Achaogen Corporation Information
Table 64. Achaogen Description and Major Businesses
Table 65. Achaogen Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 66. Achaogen Antibacterial (Drug) Resistance Product
Table 67. Achaogen Recent Developments
Table 68. Acino Holdings Corporation Information
Table 69. Acino Holdings Description and Major Businesses
Table 70. Acino Holdings Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 71. Acino Holdings Antibacterial (Drug) Resistance Product
Table 72. Acino Holdings Recent Developments
Table 73. Aventis Pharma Corporation Information
Table 74. Aventis Pharma Description and Major Businesses
Table 75. Aventis Pharma Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 76. Aventis Pharma Antibacterial (Drug) Resistance Product
Table 77. Aventis Pharma Recent Developments
Table 78. Austell Laboratories Corporation Information
Table 79. Austell Laboratories Description and Major Businesses
Table 80. Austell Laboratories Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 81. Austell Laboratories Antibacterial (Drug) Resistance Product
Table 82. Austell Laboratories Recent Developments
Table 83. Assembly Biosciences Corporation Information
Table 84. Assembly Biosciences Description and Major Businesses
Table 85. Assembly Biosciences Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 86. Assembly Biosciences Antibacterial (Drug) Resistance Product
Table 87. Assembly Biosciences Recent Developments
Table 88. Arpida Corporation Information
Table 89. Arpida Description and Major Businesses
Table 90. Arpida Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 91. Arpida Antibacterial (Drug) Resistance Product
Table 92. Arpida Recent Developments
Table 93. Demuris Corporation Information
Table 94. Demuris Description and Major Businesses
Table 95. Demuris Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 96. Demuris Antibacterial (Drug) Resistance Product
Table 97. Demuris Recent Developments
Table 98. Evolva Holding Corporation Information
Table 99. Evolva Holding Description and Major Businesses
Table 100. Evolva Holding Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 101. Evolva Holding Antibacterial (Drug) Resistance Product
Table 102. Evolva Holding Recent Developments
Table 103. ContraFect Corporation Information
Table 104. ContraFect Description and Major Businesses
Table 105. ContraFect Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 106. ContraFect Antibacterial (Drug) Resistance Product
Table 107. ContraFect Recent Developments
Table 108. Cerexa Corporation Information
Table 109. Cerexa Description and Major Businesses
Table 110. Cerexa Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 111. Cerexa Antibacterial (Drug) Resistance Product
Table 112. Cerexa Recent Developments
Table 113. InterMune Corporation Information
Table 114. InterMune Description and Major Businesses
Table 115. InterMune Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 116. InterMune Antibacterial (Drug) Resistance Product
Table 117. InterMune Recent Developments
Table 118. Isis Pharmaceuticals Corporation Information
Table 119. Isis Pharmaceuticals Description and Major Businesses
Table 120. Isis Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 121. Isis Pharmaceuticals Antibacterial (Drug) Resistance Product
Table 122. Isis Pharmaceuticals Recent Developments
Table 123. Lyndra Corporation Information
Table 124. Lyndra Description and Major Businesses
Table 125. Lyndra Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 126. Lyndra Antibacterial (Drug) Resistance Product
Table 127. Lyndra Recent Developments
Table 128. Microbecide Corporation Information
Table 129. Microbecide Description and Major Businesses
Table 130. Microbecide Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 131. Microbecide Antibacterial (Drug) Resistance Product
Table 132. Microbecide Recent Developments
Table 133. Morphochem Corporation Information
Table 134. Morphochem Description and Major Businesses
Table 135. Morphochem Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 136. Morphochem Antibacterial (Drug) Resistance Product
Table 137. Morphochem Recent Developments
Table 138. Nabriva Therapeutics Corporation Information
Table 139. Nabriva Therapeutics Description and Major Businesses
Table 140. Nabriva Therapeutics Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 141. Nabriva Therapeutics Antibacterial (Drug) Resistance Product
Table 142. Nabriva Therapeutics Recent Developments
Table 143. NanoSafe Coatings Corporation Information
Table 144. NanoSafe Coatings Description and Major Businesses
Table 145. NanoSafe Coatings Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 146. NanoSafe Coatings Antibacterial (Drug) Resistance Product
Table 147. NanoSafe Coatings Recent Developments
Table 148. Novexel Corporation Information
Table 149. Novexel Description and Major Businesses
Table 150. Novexel Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 151. Novexel Antibacterial (Drug) Resistance Product
Table 152. Novexel Recent Developments
Table 153. Osel Corporation Information
Table 154. Osel Description and Major Businesses
Table 155. Osel Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 156. Osel Antibacterial (Drug) Resistance Product
Table 157. Osel Recent Developments
Table 158. VenatoRx Pharmaceuticals Corporation Information
Table 159. VenatoRx Pharmaceuticals Description and Major Businesses
Table 160. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 161. VenatoRx Pharmaceuticals Antibacterial (Drug) Resistance Product
Table 162. VenatoRx Pharmaceuticals Recent Developments
Table 163. AAIPharma Services Corporation Information
Table 164. AAIPharma Services Description and Major Businesses
Table 165. AAIPharma Services Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 166. AAIPharma Services Antibacterial (Drug) Resistance Product
Table 167. AAIPharma Services Recent Developments
Table 168. ANTABIO Corporation Information
Table 169. ANTABIO Description and Major Businesses
Table 170. ANTABIO Antibacterial (Drug) Resistance Sales (K Units), Revenue (US$, Mn) and Gross Margin (USD/Unit) (2016-2021)
Table 171. ANTABIO Antibacterial (Drug) Resistance Product
Table 172. ANTABIO Recent Developments
Table 173. Antibacterial (Drug) Resistance Production Capacity (K Units) of Key Manufacturers in China Market, 2019-2021 (K Units)
Table 174. China Antibacterial (Drug) Resistance Capacity Market Share of Key Manufacturers, 2019-2021
Table 175. Antibacterial (Drug) Resistance Market Opportunities & Trends in China Market
Table 176. Antibacterial (Drug) Resistance Market Drivers in China Market
Table 177. Antibacterial (Drug) Resistance Market Restraints in China Market
Table 178. Antibacterial (Drug) Resistance Raw Materials
Table 179. Antibacterial (Drug) Resistance Raw Materials Suppliers in China Market
Table 180. Typical Antibacterial (Drug) Resistance Downstream
Table 181. Antibacterial (Drug) Resistance Downstream Clients in China Market
Table 182. Antibacterial (Drug) Resistance Distributors and Sales Agents in China Market
List of Figures
Figure 1. Antibacterial (Drug) Resistance Product Picture
Figure 2. Antibacterial (Drug) Resistance Segment by Type
Figure 3. Antibacterial (Drug) Resistance Segment by Indication
Figure 4. China Antibacterial (Drug) Resistance Market Overview: 2020
Figure 5. China Antibacterial (Drug) Resistance Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Antibacterial (Drug) Resistance Revenue, 2016-2027 (US$, Mn)
Figure 7. Antibacterial (Drug) Resistance Sales in China Market: 2016-2027 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Antibacterial (Drug) Resistance Revenue in 2020
Figure 9. Telavancin (Vibativ) Product Picture
Figure 10. Ceftaroline Fosamil (Teflaro/ Zinforo) Product Picture
Figure 11. Fidaxomicin (Dificid / Dificlir) Product Picture
Figure 12. Ceftobiprole Medocaril (Zevtera/ Zeftera/ Mabelio) Product Picture
Figure 13. Dalbavancin (Dalvance/ Xydalba) Product Picture
Figure 14. By Type - China Antibacterial (Drug) Resistance Sales Market Share, 2016-2027
Figure 15. By Type - China Antibacterial (Drug) Resistance Revenue Market Share, 2016-2027
Figure 16. By Type - China Antibacterial (Drug) Resistance Price (USD/Unit), 2016-2027
Figure 17. Complicated Urinary Tract Infection (CUTI)
Figure 18. Complicated Intra-Abdominal Infections (CIAI)
Figure 19. Blood Stream Infections (BSI)
Figure 20. Clostridium Difficile Infections (CDI)
Figure 21. Acute Bacterial Skin And Skin Structure Infections (ABSSSI)
Figure 22. By Indication - China Antibacterial (Drug) Resistance Sales Market Share, 2016-2027
Figure 23. By Indication - China Antibacterial (Drug) Resistance Revenue Market Share, 2016-2027
Figure 24. By Indication - China Antibacterial (Drug) Resistance Price (USD/Unit), 2016-2027
Figure 25. Melinta Therapeutics Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Allergan Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. Merck Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. Abbott Laboratories Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 29. Pfizer Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 30. GSK Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 31. PENDOPHARM Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 32. Absynth Biologics Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 33. Achaogen Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 34. Acino Holdings Antibacterial (Drug) Resistance Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 35. Aventis Pharma Antibacterial (Drug) Resistance Revenue Ye

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs